New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
16:12 EDTALBAlbermarle expands share repurchase authorization to 15M shares
The Board of Directors of Albermarle authorized an increase in the number of shares the company is permitted to repurchase under its existing share repurchase program to 15M from 3.9M shares that remained outstanding under the program as of December 31, 2012. The company currently expects to repurchase approximately 10% of its outstanding shares over the next 10 to 15 months. Share repurchases will be funded through a combination of available cash on hand, free cash flow and possibly debt, the company said.
News For ALB From The Last 14 Days
Check below for free stories on ALB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
09:29 EDTALBAlbemarle says sale of assets to SI Group was due to a need to consolidate
Subscribe for More Information
April 16, 2014
17:16 EDTALBAlbemarle reports Q1 adjusted EPS 96c, consensus 95c
Reports Q1 revenue $656.68M, consensus $655.87M.
16:05 EDTALBAlbemarle agrees to sell antioxidant, ibuprofen and propofol businesses
Albemarle Corporation announced that it has signed a definitive agreement to sell certain assets to SI Group. Included in the transaction are Albemarle's antioxidants and FDA-regulated ibuprofen and propofol businesses and assets, with manufacturing sites in Orangeburg, South Carolina and Jinshan, China; and Albemarle's antioxidant product lines. Certain applications and technical support capabilities in Shanghai, China and Baton Rouge, Louisiana will also be included in the transaction. Terms of the transaction, which is subject to customary closing conditions and is expected to close later in 2014, were not disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use